Pentadecanoic acid, 2-(dimethylamino)ethyl ester

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 脂肪酰基
• 英文名称: Pentadecanoic acid, 2-(dimethylamino)ethyl ester
• 英文别名: 2-(dimethylamino)ethyl pentadecanoate
• 化学式: C₁₉H₃₉NO₂
• 分子量: 313.524
• InChiKey: YDAFEAGUDJFURU-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  6.9
• 重原子数：
  22
• 可旋转键数：
  17
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.95
• 拓扑面积：
  29.5
• 氢给体数：
  0
• 氢受体数：
  3

反应信息

• 作为产物：
  描述：

  N,N-二甲基乙醇胺 、 十五烷酸 反应 4.0h， 生成 Pentadecanoic acid, 2-(dimethylamino)ethyl ester
  参考文献：
  名称：

  Ryzhkov, Yu. A.; Voronchikhina, L. I., Russian Journal of Applied Chemistry, 1994, vol. 67, # 5.2, p. 734 - 736

  摘要：

  DOI：

文献信息

• [EN] POLYAMINE-FATTY ACID DERIVED LIPIDOIDS AND USES THEREOF<br/>[FR] LIPIDOÏDES DÉRIVÉS DE POLYAMINE-ACIDE GRAS ET LEURS UTILISATIONS
  申请人：MASSACHUSETTS INST TECHNOLOGY

  公开号：WO2016004202A1

  公开（公告）日：2016-01-07

  The present disclosure provides polyamine-fatty acid derived lipidoids (e.g., compounds of Formula (I) or (II)) and methods of preparing the lipidoids. A described lipidoid includes R-C(=0)-0- moieties (where R is a lipid moiety), which may be hydrolyzed into non-toxic fatty acids. Also provided are compositions including a described lipidoid and an agent (e.g., polynucleotide, small molecule, peptide, or protein). The present disclosure also provides methods, kits, and uses that involve the lipidoids or compositions for delivering an agent to a subject, tissue, or cell and/or for treating and/or preventing a range of diseases, such as genetic diseases, proliferative diseases, hematological diseases, neurological diseases, immunological diseases, gastrointestinal diseases, respiratory diseases, painful conditions, psychiatric disorders, and metabolic disorders.

  本公开提供了聚胺脂肪酸衍生的脂质体（例如，化合物的化学式（I）或（II））以及制备脂质体的方法。所述脂质体包括R-C(=0)-0-基团（其中R是脂质基团），可以水解为无毒脂肪酸。还提供了包括所述脂质体和药剂（例如，多核苷酸、小分子、肽或蛋白质）的组合物。本公开还提供了涉及脂质体或组合物用于将药剂传递给受体、组织或细胞和/或用于治疗和/或预防一系列疾病的方法、试剂盒和用途，例如遗传疾病、增殖性疾病、血液疾病、神经系统疾病、免疫系统疾病、胃肠道疾病、呼吸系统疾病、疼痛症状、精神障碍和代谢性疾病。
• Method of improving the electrical conductivity of a molding artcile of resin, method of coating a molding article of resin, and coating composition
  申请人：NIPPON PAINT CO., LTD.

  公开号：EP0764663A2

  公开（公告）日：1997-03-26

  There is provided a method for coating a molded resin article such as an automotive part, and improving its electrical conductivity by a high productivity procedure which avoids using an inorganic conductive primer. The substrate is coated with a composition containing a film-forming component and a specified nitrogen-containing compound and the coated surface is subjected to corona discharge treatment and is then optionally electrostatically coated.

  本发明提供了一种涂覆模塑树脂制品（如汽车零件）的方法，该方法采用高生产率程序，避免使用无机导电底漆，从而提高了其导电性。在基材上涂覆一种含有成膜成分和特定含氮化合物的组合物，然后对涂覆表面进行电晕放电处理，再选择性地进行静电涂覆。
• Polymer, resist protective coating material, and patterning process
  申请人：Harada Yuji

  公开号：US20080085466A1

  公开（公告）日：2008-04-10

  A resist protective coating material comprises a polymer comprising repeat units having formulae (1 a ) and (1 b ) and having a Mw of 1,000-500,000. R 1a and R 1b are H, F or alkyl or fluoroalkyl, R 2a , R 2b , R 3a and R 3b are H or alkyl, or R 2a and R 2b , and R 3a and R 3b may bond together to form a ring, 0
• POLYAMINE-FATTY ACID DERIVED LIPIDOIDS AND USES THEREOF
  申请人：Massachusetts Institute of Technology

  公开号：US20160002178A1

  公开（公告）日：2016-01-07

  The present disclosure provides polyamine-fatty acid derived lipidoids (e.g., compounds of Formula (I) or (II)) and methods of preparing the lipidoids. A described lipidoid includes R—C(═O)—O— moieties (where R is a lipid moiety), which may be hydrolyzed into non-toxic fatty acids. Also provided are compositions including a described lipidoid and an agent (e.g., polynucleotide, small molecule, peptide, or protein). The present disclosure also provides methods, kits, and uses that involve the lipidoids or compositions for delivering an agent to a subject, tissue, or cell and/or for treating and/or preventing a range of diseases, such as genetic diseases, proliferative diseases, hematological diseases, neurological diseases, immunological diseases, gastrointestinal diseases, respiratory diseases, painful conditions, psychiatric disorders, and metabolic disorders.
• US5858472A
  申请人：——

  公开号：US5858472A

  公开（公告）日：1999-01-12